Skip to main content

Table 2 Distribution of genotype and allele frequencies of the  hOGG1  Ser326Cys polymorphism

From: An association between hOGG1Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis

First author [reference] Genotype Allele HWE( p )
Cases n (%) Controls n (%) Cases n (%) Controls n (%)
Ser/Ser Ser/Cys Cys/Cys Ser/Ser Ser/Cys Cys/Cys Ser Cys Ser Cys
Kim (2005) [19] 37 (24.2%) 90 (58.8%) 26 (17.0%) 38 (24.8%) 70 (45.6%) 45 (29.4%) 164 (53.6%) 142 (46.4%) 146 (47.7%) 160 (52.3%) 0.30
Karahalil (2006) [23] 40 (40.4%) 47 (47.5%) 12 (12.1%) 62 (62.0%) 20 (20.0%) 18 (18.0%) 127 (64.1%) 71 (35.9%) 144 (72.0%) 56 (28.0%) <0.001
Huang (2007) [21] 375 (61.2%) 209 (34.1%) 29 (4.73%) 348 (58.0%) 216 (36.0%) 36 (6%) 959 (78.2%) 267 (21.8%) 912 (76.0%) 288 (24.0%) 0.75
Figueroa (2007) [20] 649 (59.7%) 383 (35.2%) 56 (5.15%) 596 (58.5%) 361 (35.5%) 61 (5.99%) 1681 (77.3%) 495 (22.7%) 1553 (76.3%) 483 (23.7%) 0.52
Arizono (2008) [17] 61 (24.3%) 107 (42.6%) 83 (33.1%) 67 (26.7%) 135 (53.8%) 49 (19.5%) 229 (45.6%) 273 (54.4%) 269 (53.6%) 233 (46.4%) 0.20
Narter (2009)[22] 37 (63.8%) 13 (22.4%) 8 (13.8%) 18 (50.0%) 18 (50.0%) 0 (0%) 87 (75.0%) 29 (25.0%) 54 (75.0%) 18 (25.0%) 0.08
Mittal (2011) [31] 92 (43.4%) 93 (43.9%) 27 (12.7%) 122 (48.8%) 111 (44.4%) 17 (6.8%) 277 (65.3%) 147 (34.7%) 355 (71.0%) 145 (29.0%) 0.21
Total 1291 (52.2%) 942 (38.1%) 241 (9.74%) 1251 (52.0%) 931 (38.7%) 226 (9.39%) 3524 (71.2%) 1424 (28.8%) 3433 (71.3%) 1383 (28.7%) 0.006